TIS and IDEMIA Join Forces to Provide Biometric Digital Identity Solutions for Financial Institutions, Using IDEMIA’s Digital Identity Platform for Research and Development
Going forward, the two companies aim to conduct verification testing in Japan throughout 2018 targeted at financial institutions such as banks and credit card companies, amongst others, through joint research and development of highly secure and reliable biometric digital identity solutions based on IDEMIA’s digital identity and payment platform.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180531005666/en/
Biometric digital identity solutions for financial institutions are solutions that support the utilization of digital identity technologies, including biometric authentication, identity verification, and digital signatures. The incorporation of advanced digital identity technologies will enable the development of secure and convenient services for end users.
TIS has developed the brand-name of “PAYCIERGE”, based on its rich experience with development of critical systems for credit card companies and cutting-edge technologies. It has developed a broad range of services, from business systems that perform debit and prepaid card processing to mobile solutions in close proximity to the consumer for enhancing user convenience.
IDEMIA is the global leader in the fields of biometrics (fingerprint, facial and iris authentication), digital identity, and payment solutions. It has dozens of years of expertise worldwide, across the entire value chain in the field of Augmented Identity and provides numerous public and private markets with the most exhaustive digital trust suite (identity-verification technologies, risk-based authentication, Omni-channel online contracts, digital payments, etc.).
TIS and IDEMIA are now aiming to blend the two companies’ technologies to offer highly reliable and convenient mobile-based biometric digital identity solutions for financial institutions such as banks and credit card companies.
The following outline some of its uses:
- Enabling the opening of a bank account within just a few minutes from a remote location while maintaining regulatory (KYC*, AML*, etc.) compliance.
- Using facial authentication for secure access and performing highly-sensitive transactions (funds transfers and online payments).
- Enabling enrolment anytime, anywhere, and on any device in any type of financial product (loans, savings, life insurance, etc.) in a legally-compliant form.
TIS has been developing the new concept “PAYCIERGE 2.0” since 2016, which is adapted to the needs of the ever-evolving payments business market and offering the new solutions to this market. The linkage of the biometric authentication technology and services of IDEMIA with the financial industry experience and technologies acquired by TIS will increase the value of services in the consumer domain and create a variety of payment services with high levels of security and usability.
Pierre Barrial, Executive Vice-President of IDEMIA’s Financial Institutions Business Unit, made the following comments with respect to this joint research: “I am proud of our partnership with TIS. By combining IDEMIA’s best-in-class knowledge in ID integration and TIS’s outstanding IS integration, we can create superior value-added services for Japanese financial institutions, acquire new customers, speed up market entry, and reduce integration costs.”
Kiyotaka Nakamura, TIS Managing Executive Officer and Division Manager of the Payment Services Division of the Service Strategy Sector, made the following comments: “I am very happy that we were able to announce the research and development efforts with IDEMIA, the global leader in Augmented Identity. TIS has been developing “PAYCIERGE” solutions, but the importance of security and usability has become clear with recent progress in FinTech. We will see business innovation and market creation in the payments domain utilizing the experience and technologies acquired by TIS and the security technologies and high-usability solutions of IDEMIA.”
*KYC: Know Your Customer
*AML: Anti-Money Laundering
TIS retail payments solution, “PAYCIERGE”, is the comprehensive brand for retail payment solutions that provide very convenient, secure mechanisms to all customers who need to make retail payments. “PAYCIERGE 2.0” is a new concept adapted to the needs of the ever-evolving payments business market. It helps broadly with business success by incorporating reliable systems and secure operations that leverage the advanced technologies, which have an overwhelming market share in the credit card industry, and rich know-how of TIS under the theme of “connections”, which includes strengthening “connections” by making alliances, strengthening “connections” with an open API platform, and developing overseas markets.
For more details, please refer to the following URL:
TIS of TIS INTEC Group offers a variety of service-oriented IT solutions, such as data centers and cloud IT solutions in addition to SI and commissioned development. At the same time, it has a global support system centralized in the China and ASEAN region, which supports more than 3000 business partners in various industries such as finance, manufacturing, distribution/service, public sector, and communications to contribute to the growth of our customers’ businesses.
For more details, please refer to the following URL:
OT-Morpho is now IDEMIA, the global leader in Augmented Identity, with
the ambition to empower citizens and consumers alike to interact, pay,
connect, travel, and vote in ways that are now possible in a connected
Securing our identities has become mission critical in the world we live in today. By standing for Augmented Identity, we reinvent the way we think, produce, use and protect this asset, whether for individuals or for objects. We ensure privacy and trust as well as guarantee secure, authenticated and verifiable transactions for international clients from Financial, Telecom, Identity, Public Security and IoT sectors.
OT (Oberthur Technologies) and Safran Identity & Security (Morpho) have joined forces to form IDEMIA. With close to $3 billion in revenue and 14,000 employees around the world, IDEMIA serves clients in 180 countries.
HAVAS PARIS PR Agency
Corporate Planning SBU
Corporate Communication Department
Details for inquiries:
Service Strategy Secto
Payment Services Division
PAYCIERGE general contact
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy21.5.2019 08:00:00 EEST | Tiedote
Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005695/en/ Vifor Pharma today announced that treatment of the first patient in their global phase-IIIb DIAMOND study has begun. The study will evaluate the potential of Veltassa® to improve outcomes by enabling heart failure (HF) patients, with or without chronic kidney disease (CKD), to be treated with renin-angiotensin-aldosterone system inhibitors (RAASi) therapy in accordance with HF treatment guidelines1,2. Presently, RAASi treatment is frequently discontinued due to the risk of hyperkalaemia (elevated blood potassium levels). The DIAMOND study is designed to further support the use of Veltassa® to effectively control high blood potassium levels, thereby enabling optimal RAASi therapy in HF patients. It is a global, multicentre, double-blind, placebo-controlled trial aiming to study approximately 2,400 patients in over 400 sites. Eligible patients wil
Concierge Auctions and Engel & Völkers to Sell $29.9 Million New Jersey Estate Without Reserve20.5.2019 20:32:00 EEST | Tiedote
A 32,507-square-foot Saddle River residence will sell at auction next month via leading global firm Concierge Auctions. Known as “Stone Palace on the Hill,” the home features a glass elevator, tennis court, racquetball court, wine cellar, and two swimming pools. 144 East Saddle River Road was previously listed for $29.9 million and will sell Without Reserve in cooperation with Alina Pogorelova and Lisa Troyano-Ascolese of Engel & Völkers. Bidding, which will be held via Concierge Auctions’ online marketplace, will open on June 21st and close on June 27. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005686/en/ 144 East Saddle River Road | New York Metro, NJ (Photo: Business Wire) “The quality of work and detail that went into building this home is perhaps the most impressive element of the property,” said Troyano-Ascolese. “With astounding details from custom gold-plated and forged-iron railings to a complete hand-cut
CNIM to Optimize Renewable Heat Production for Nantes District Heating20.5.2019 20:20:00 EEST | Tiedote
CNIM, a French international industrial equipment manufacturer and integrator, has entered into an agreement concerning the energy efficiency optimisation at the waste-to-energy plant serving the cities of Nantes and Saint Nazaire, in the North West of France. Under the terms of this agreement, CNIM will install an absorption heat pump to boost the supply of hot water to Nantes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190520005678/en/ Heat-Pump_13MW_Brive (c) CNIM The delivery is scheduled for October 2019. The new system has been designed to inject 3.1 MW of heat energy into Nantes' district heating system. 2018: Two contracts to upgrade heat networks in France and Switzerland Prior to this agreement, CNIM won two other major contracts to upgrade the energy efficiency of waste-to-energy plants in France and Switzerland, and to supply district heating networks with renewable energy. Supplying 30 MW to Basel's district
Phase III study showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis associated ILD120.5.2019 19:46:00 EEST | Tiedote
Boehringer Ingelheim today announced that the SENSCIS® trial met its primary endpoint: reduction in the annual rate of decline in forced vital capacity (FVCa) in patients with systemic sclerosis associated interstitial lung disease (SSc-ILD). Results show that nintedanib slows the loss of pulmonary function in patients with SSc-ILD compared to placebo. Patients taking nintedanib showed a 44% reduction in the rate of decline of their lung function, measured in FVC assessed over 52 weeks1. These new data were today published in the New England Journal of Medicine (NEJM) and presented to the medical community at the American Thoracic Society (ATS) International Conference, in Dallas, USA. SENSCIS® is the largest randomised controlled trial to be conducted in patients with SSc-ILD, a disease for which there are currently no approved treatments.1,3,4 Results also showed that nintedanib had a safety and tolerability profile similar to that observed in patients with idiopathic pulmonary fibro
MyHeritage laajenee terveyteen lanseeramalla uuden DNA-testin, joka tarjoaa kuluttajille yksilöllistä tietoa terveydestä20.5.2019 18:55:00 EEST | Tiedote
MyHeritage, maailman johtava perhehistoria- ja DNA-testauspalvelu, ilmoitti tänään DNA-tuotevalikoimansa merkittävästä laajenemisesta MyHeritage Terveys+Perimä DNA-testin lanseeraamisen myötä. Testi tarjoaa uuden ulottuvuuden geneettiseen tietoon kattavien terveysraporttien avulla, mikä voi vaikuttaa terveys- ja elämäntapavalintoihin tulevaisuudessa. Se on nykyisen MyHeritage Vain-Perimä DNA-testin supersetti ja sisältää sen peruspilarit: etnisen alkuperän prosentuaalisen jakauman ja yhteisen, jaetun DNAn avulla löytyneet sukulaiset. MyHeritage on nyt ainoa maailmanlaajuinen DNA-yritys, joka tarjoaa kuluttajille kattavan terveys- ja perimä-tuotteen yli 40 kielellä. Tämä lehdistötiedote sisältää multimediaa. Katso koko julkaisu täällä: https://www.businesswire.com/news/home/20190520005590/fi/ MyHeritage laajenee terveyteen lanseeramalla uuden DNA-testin, joka tarjoaa kuluttajille yksilöllistä tietoa terveydestä (Graphic: Business Wire) Terveys+Perimä-tuotteen lanseeraus erottaa MyHerita
Airship Bolsters its Senior Leadership Team for Accelerated Global Growth20.5.2019 16:00:00 EEST | Tiedote
Customer engagement company Airship today announced four senior leadership appointments including Dale Flores as vice president of sales Americas, Neil Gariepy as vice president of infrastructure and security, David King Harris as vice president of sales EMEA, and Jeff Winsor as vice president of technology services. Dale Flores will lead the rapid expansion of Airship’s Americas sales organization, growing solution adoption to generate greater business value for customers throughout the region. Flores brings two decades of global SaaS sales and customer success management experience to Airship, including over 14 years leading sales teams at Silverpop and IBM. Most recently, Flores was head of customer success at digital customer experience company Clicktale. Neil Gariepy will lead Airship’s customer engineering, infrastructure and security teams, with responsibility for expanding Airship’s infrastructure globally while further optimizing its cost, performance and security. Gariepy bri
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme